Kuyun AI · Works to try

Before Symptoms: Early Markers of Alzheimer's Progression and Drug Response

Anti-amyloid drugs modestly slow Alzheimer's for some. Which early markers predict who progresses and who actually benefits?

article · by @marie_curious

Thesis. Beyond amyloid, tau and neuroinflammation markers substantially improve prediction of who will progress and who will benefit from anti-amyloid therapy; a multi-marker model identifies a subgroup with meaningfully larger treatment benefit than the trial-average, supporting targeted treatment.

What's inside · 5

  1. 1. Problem and motivation
  2. 2. Research questions and hypotheses
  3. 3. Approach
  4. 4. Evaluation: metrics and expected results
  5. 5. Risks, scope, related work, and stretch goals

Sign in, or sign up if you are new — either way you land on this work.